Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rajat Kumar

Showing results (271-280 of 341) with videos related to

Pageof 35
Sort By:
Hematology/Oncology and Stem Cell Therapy|October 13, 2020
Outcomes of adult patients with acute myeloid leukemia and unsuccessful cytogenetic analysis undergoing allogeneic hematopoietic stem cell transplantationRam Vasudevan Nampoothiri, Shiyi Chen, Ivan Pasic, et al.
Leukemia & Lymphoma|May 14, 2026
CMV reactivation post allogeneic stem cell transplantation decreases relapse risk and survival, and increases NRM - a single center analysisVered Stavi, Carol Chen, Igor Novitzky-Basso, et al.
European Journal of Haematology|July 14, 2021
Effect of pre-transplant JAK1/2 inhibitors and CD34 dose on transplant outcomes in myelofibrosisSunu Cyriac, Shruti Prem, Maria Queralt Salas, et al.
Annals of Hematology|February 23, 2023
Impact of age on hospitalization and outcomes post allogeneic hematopoietic cell transplantation outcome, a single center experienceEshrak Al-Shaibani, Shiyi Chen, Carol Chen, et al.
Transplantation and Cellular Therapy|May 9, 2021
Experience Using Anti-Thymocyte Globulin With Post-Transplantation Cyclophosphamide for Graft-Versus-Host Disease Prophylaxis in Peripheral Blood Haploidentical Stem Cell TransplantationMaria Queralt Salas, Eshetu G Atenafu, Arjun Datt Law, et al.
Blood Cell Therapy|January 30, 2023
High Overall and GVHD-Free Survival in Patients with Aplastic Anemia Receiving <i>in vivo</i> T-cell Depletion Transplants and Long-Term ComplicationsMaria Queralt Salas, Eshetu G Atenafu, Wilson Lam, et al.
Transplantation and Cellular Therapy|July 15, 2025
Effect of Anti-Thymocyte Globulin and Post-Transplant Cyclophosphamide on Graft-Versus-Host Disease Outcomes in Female Donor-to-Male Recipient Matched Unrelated Donor Allogeneic Stem Cell Transplantation for Acute LeukemiaNihar Desai, Sergio Rodriguez-Rodriguez, Mats Remberger, et al.
JCO Oncology Practice|June 29, 2026
Impact of Graft-Versus-Host Disease Prophylaxis on Long-Term Outcomes in Patients Surviving Beyond Two Years After Allogeneic TransplantationNihar Desai, Sergio Rodriguez-Rodriguez, Carol Chen, et al.
Vaccine|July 24, 2019
Immunogenicity and safety of a liquid Pentavalent (DTwP-Hb-Hib) combination vaccine manufactured by Human Biologicals Institute in 6-8 weeks old healthy infants: A phase III, randomized, single blind, non-inferiority studySai Krishna Susarla, Madhu Gupta, Mukta Mantan, et al.
Bone Marrow Transplantation|February 7, 2020
Dual T-cell depletion with ATG and PTCy for peripheral blood reduced intensity conditioning allo-HSCT results in very low rates of GVHDMaria Queralt Salas, Shruti Prem, Eshetu G Atenafu, et al.
Pageof 35

Showing results (271-280 of 341) with videos related to

Sort By:
Pageof 35
Hematology/Oncology and Stem Cell Therapy|October 13, 2020
Outcomes of adult patients with acute myeloid leukemia and unsuccessful cytogenetic analysis undergoing allogeneic hematopoietic stem cell transplantationRam Vasudevan Nampoothiri, Shiyi Chen, Ivan Pasic, et al.
Leukemia & Lymphoma|May 14, 2026
CMV reactivation post allogeneic stem cell transplantation decreases relapse risk and survival, and increases NRM - a single center analysisVered Stavi, Carol Chen, Igor Novitzky-Basso, et al.
European Journal of Haematology|July 14, 2021
Effect of pre-transplant JAK1/2 inhibitors and CD34 dose on transplant outcomes in myelofibrosisSunu Cyriac, Shruti Prem, Maria Queralt Salas, et al.
Annals of Hematology|February 23, 2023
Impact of age on hospitalization and outcomes post allogeneic hematopoietic cell transplantation outcome, a single center experienceEshrak Al-Shaibani, Shiyi Chen, Carol Chen, et al.
Transplantation and Cellular Therapy|May 9, 2021
Experience Using Anti-Thymocyte Globulin With Post-Transplantation Cyclophosphamide for Graft-Versus-Host Disease Prophylaxis in Peripheral Blood Haploidentical Stem Cell TransplantationMaria Queralt Salas, Eshetu G Atenafu, Arjun Datt Law, et al.
Blood Cell Therapy|January 30, 2023
High Overall and GVHD-Free Survival in Patients with Aplastic Anemia Receiving <i>in vivo</i> T-cell Depletion Transplants and Long-Term ComplicationsMaria Queralt Salas, Eshetu G Atenafu, Wilson Lam, et al.
Transplantation and Cellular Therapy|July 15, 2025
Effect of Anti-Thymocyte Globulin and Post-Transplant Cyclophosphamide on Graft-Versus-Host Disease Outcomes in Female Donor-to-Male Recipient Matched Unrelated Donor Allogeneic Stem Cell Transplantation for Acute LeukemiaNihar Desai, Sergio Rodriguez-Rodriguez, Mats Remberger, et al.
JCO Oncology Practice|June 29, 2026
Impact of Graft-Versus-Host Disease Prophylaxis on Long-Term Outcomes in Patients Surviving Beyond Two Years After Allogeneic TransplantationNihar Desai, Sergio Rodriguez-Rodriguez, Carol Chen, et al.
Vaccine|July 24, 2019
Immunogenicity and safety of a liquid Pentavalent (DTwP-Hb-Hib) combination vaccine manufactured by Human Biologicals Institute in 6-8 weeks old healthy infants: A phase III, randomized, single blind, non-inferiority studySai Krishna Susarla, Madhu Gupta, Mukta Mantan, et al.
Bone Marrow Transplantation|February 7, 2020
Dual T-cell depletion with ATG and PTCy for peripheral blood reduced intensity conditioning allo-HSCT results in very low rates of GVHDMaria Queralt Salas, Shruti Prem, Eshetu G Atenafu, et al.
Pageof 35